Check out these can’t-miss dermatology stories published this month.
The Flawless Fallacy: A Pharmacist’s Guide to Skin Care in the Digital Age
Cutting through the noise of social media is key when educating patients on how to make better choices for their skin.
Sunscreen Safety: What Every Pharmacist Needs to Know
Warm weather means one thing: People are eager to be outdoors. Although sun protection is paramount, sunscreen options can be daunting. How can pharmacists help?
Slideshow: The Gut-Skin Connection
Recent research exploring the gut-skin connection shows that dietary modifications and probiotic supplements may help skin conditions like acne, atopic dermatitis, and rosacea.
Q&A: Clinical Pearls in Skin Cancer Awareness for the Community Pharmacist
For Melanoma and Skin Cancer Awareness Month, Drug Topics sat down with Colleen McCabe, PharmD, BCOP, to glean clinical insights into promoting skin cancer awareness in the community pharmacy.
Slideshow: AI in Skin Cancer Awareness Creates New Opportunities for Care
Research exploring the growing role of artificial intelligence (AI) in health care sheds a light on the potential of the technology to improve skin cancer detection and awareness among patients and health care professionals.
OTC Product Roundup: Skin Care
Spring and summer not only bring sunshine, but also stronger UV rays. Whether you are barbecuing, swimming, or taking a hike, skin protection is paramount while soaking up the sunshine.
FDA Approves Novel Topical Therapy for Molluscum Contagiosum
Berdazimer topical gel is the first in its class and is the only topical prescription medication to treat molluscum contagiosium that can be applied by patients or caregivers outside of a medical setting.
READ MORE: Dermatology Resource Center
Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
FDA Approves Lebrikizumab-lbkz for Moderate-to-Severe Atopic Dermatitis
September 16th 2024Lebrikizumab-lbks is a targeted treatment that addresses the root cause of atopic dermatitis; by reducing inflammation throughout the body, it can help alleviate the dry, itchy, and irritated skin that often characterizes the condition.